Nature provides a valuable resource of medicinally relevant compounds, with many antimicrobial and antitumor agents entering clinical trials being derived from natural products. The generation of analogues of these bioactive natural products is important in order to gain a greater understanding of structure activity relationships; probing the mechanism of action, as well as to optimise the natural product's bioactivity and bioavailability. This chapter critically examines different approaches to generating natural products and their analogues, exploring the way in which synthetic and biosynthetic approaches may be blended together to enable expeditious access to new designer natural products.
CITATION STYLE
Zarins-Tutt, J. S., Abraham, E. R., Bailey, C. S., & Goss, R. J. M. (2017, January 1). Bluegenics: Bioactive Natural Products of Medicinal Relevance and Approaches to Their Diversification. Progress in Molecular and Subcellular Biology. https://doi.org/10.1007/978-3-319-51284-6_5
Mendeley helps you to discover research relevant for your work.